查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2129016

轉導增強劑市場：依產品類型、應用、標靶細胞類型、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Transduction Enhancer Reagents Market, By Product Type, By Application, By Target Cell Type, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 394 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，轉導增強劑試劑市場價值將達到 1.208 億美元，從 2026 年到 2033 年將以 8.4% 的複合年成長率成長。

轉導增強劑樣本市場涵蓋多種化學物質、胜肽和製劑添加劑，旨在提高病毒載體進入目標細胞的效率。該市場提供種類繁多的增強劑產品、轉導試劑盒和其他用於研究應用的樣品形式。此應用領域的主要促進因素是需要提高慢病毒和逆轉錄病毒在具有挑戰性的條件下（例如病毒-細胞相互作用減弱、抗病毒活性有限以及在原代細胞和幹細胞群體中轉導率降低）的遞送效率。此外，據報道，LentiBOOST、TransDux 和 LentiBlast 等商業產品旨在滿足日益成長的對試劑一致性、細胞活力和與治療藥物開發相容性的需求，而不僅僅是提高感染性。 2025 年發表的一項研究表明，增強劑的選擇可以顯著影響各種具有挑戰性的細胞類型中的轉導結果，這表明該市場在實現病毒基因轉移過程中發揮重要作用。

轉導增強劑試劑市場 - 市場動態

在轉導困難的原代細胞中，對高性能轉導的需求日益成長。

市場的主要促進因素正從基本的病毒攝取轉向實現對難以轉染的細胞類型的穩定基因遞送。 2025年的一篇綜述指出，細胞質量、所用載體、培養條件和增強劑等因素相互關聯，共同影響有效的轉導。然而，每種產品的生產方法仍然各不相同。實驗證據也支持這項需求。 2025年一項針對人類視網膜色素上皮細胞的研究發現，無論濃度如何，聚布倫都能提高慢病毒的轉染效率，其最佳濃度為10 μg/ml，而聚布倫與硫酸魚精蛋白聯用可使GFP陽性細胞的比例達到65.4%。因此，試劑供應商之間的競爭日益激烈，不僅體現在增強效果上，還體現在性能的可預測性、細胞相容性和製程整合性。

轉導增強劑試劑市場－市場區隔分析：

全球轉導增強劑試劑市場按產品類型、應用、目標細胞類型和地區進行細分。

從產品類型來看，產品配置主要取決於轉導工作流程的複雜程度。獨立轉導增強劑提供最廣泛的客製化選擇，因為其化學結構可以根據每個選定的載體和細胞類型進行調整。 LentiBOOST、TransDux 和 LentiBlast 透過促進病毒與細胞相互作用的多種作用機制體現了這項特性。另一方面，轉導試劑盒代表了一種更整合的病毒轉導方法，無論是在捆綁式組件還是標準化試劑配方方面，都有助於降低整個實驗室內部流程的變異性。 「其他」類別包括針對特定載體或細胞的其他專用形式和試劑類型。因此，競爭格局正日益從種類繁多的試劑轉向有助於簡化最佳化流程的專用形式，這一點尤其受到轉化研究最終用戶的關注。

從應用角度來看，應用特定需求似乎是推動市場需求的主要因素。細胞療法可望從體外對原代免疫細胞和幹細胞進行基因修飾中獲益最多。在該領域，高轉導效率、高細胞活力和高功能評估至關重要。一項2025年發表的關於人類和恒河猴NK細胞增殖和轉導的研究強調了泊洛沙姆407在增殖的恒河猴NK細胞中實現60%轉導率的潛力，且未觀察到細胞活力或功能的下降。基因療法類似地涉及將標靶治療基因導入標靶細胞，而疫苗研發則可能利用病毒載體來生產編碼抗原並免疫抗原性。因此，細胞療法和基因療法的應用領域有望從標準化和可重複的流程中獲益最多。

轉導增強劑試劑市場－區域分析

北美市場的主要驅動力在於其強大的細胞和基因療法商業基礎設施，以及在各種治療開發平臺中對轉導技術的應用。 2025年，美國監管機構持續認可基因修飾細胞療法日益成長的臨床意義，例如，FDA於6月取消了目前已獲批准的針對BCMA和CD19的自體CAR-T免疫療法的風險評估和緩解策略（REMS）要求。此外，FDA於2025年11月批准了一種基於腺相關病毒（AAV）的脊髓性肌肉萎縮症基因療法，這是載體領域的另一個監管里程碑。隨著治療平台日趨成熟，對可重複的上游工程細胞工程製程的需求也日益成長，這些進展對增強子供應商意義重大，並進一步推動了區域內研究和轉化轉導試劑市場的發展。

歐洲擁有獨特的機遇，這得益於其嚴格的法規環境，有利於先進療法的研發，以及在基因和細胞工程領域深厚的研究實力。歐洲藥品管理局 (EMA) 已通過修訂版的在臨床實驗先進療法產品 (ATMP) 的品質、非臨床和臨床要求指南，該指南於 2025 年 7 月生效。這凸顯了在歐洲範圍內對先進療法進行受控開發和表徵的必要性。 2025 年，歐洲的臨床研發趨勢同樣活躍，當年發布的一項分析顯示，四個資料庫中共註冊了 2008 項 ATMP 臨床試驗，涵蓋了基因、細胞和組織療法等多種治療方法。此外，歐洲的研究機構也持續探索增強子生物學的基本原理；例如，法國國家健康與醫學研究院 (Inserm) 的最新研究揭示了貝克托夫辛和CyclosporineH 能夠克服細胞限制機制。綜上所述，這些都凸顯了歐洲市場對細胞和基因編輯技術的獨特吸引力。

目錄

第1章：轉導增強劑試劑市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：轉導增強劑試劑的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：轉導增強劑試劑的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：轉導增強劑試藥市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：轉導增強劑試劑的市場趨勢

  • 轉導增強劑試劑市佔率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 轉導增強劑試劑市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 轉導增強劑
    • 轉換套件
    • 其他

第8章：轉導增強劑試劑市場：依應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 疫苗
    • 基因治療
    • 細胞療法
    • 其他

第9章：轉導增強劑試劑市場：以標靶細胞類型分類

  • 概述
    • 細分市場佔有率分析：依目標細胞類型
    • 幹細胞
    • 免疫細胞
    • 癌細胞
    • 其他

第10章：轉導增強劑試劑市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：感測增強劑試劑產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Thermo Fisher Scientific
    • Takara Bio Inc.
    • Bio-Techne
    • System Biosciences（SBI）
    • Miltenyi Biotec
    • Applied Biological Materials
    • OZ Biosciences
    • Revvity
    • Virongy
    • BPS Bioscience
    • komabiotech
    • ABP Biosciences
    • Merck KGaA（MilliporeSigma）
    • Lonza Group
    • Origene Technologies
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7353

Transduction Enhancer Reagents Market size was valued at US$ 120.8 Million in 2025, expanding at a CAGR of 8.4% from 2026 to 2033.

The transduction enhancer reagents market includes various chemicals, peptides, and formulation additives designed to improve the viral vector entry efficiency into target cells. The market offers a range of enhancer products, transduction kits, and other reagent formats for research applications. The application field is mainly driven by the need to increase lentiviral and retroviral delivery efficiency in challenging environments, such as reduced virus-cell interaction, antiviral restriction, and reduced transduction rates of primary and stem cell populations. Moreover, commercial examples, including LentiBOOST, TransDux, and LentiBlast, have been reported to address a growing need for reagents offering consistency, cell viability, and therapeutic development compatibility rather than enhanced infectivity. According to research published in 2025, the choice of enhancer could significantly impact the transduction outcome in a range of challenging cell types, indicating the market's role as an enabler of the viral gene transfer process.

Transduction Enhancer Reagents Market- Market Dynamics

Demand for Higher-Performance Transduction in Difficult Primary Cells

The key market driver is evolving from basic viral uptake to obtaining consistent gene delivery into cell types that are inherently difficult to transfect. The 2025 review noted that factors such as cell quality, vectors used, incubation conditions, and enhancers are interrelated drivers for effective transduction; although manufacturing methods continue to be unique for each specific product. Experimental proof confirms this need: according to the 2025 research on human retinal pigment epithelial cells, polybrene improved lentiviral transfection efficacy regardless of concentration, with optimal individual effect at a 10 μg/ml concentration and the combination of polybrene and protamine sulfate reaching 65.4% GFP-positive cells. Hence, suppliers of reagents are increasingly competing on performance predictability, cell compatibility, and process integration, and not just enhancement.

Transduction Enhancer Reagents Market- Segmentation Analysis:

The Global Transduction Enhancer Reagents Market is segmented on the basis of Product Type, Application, Target Cell Type, and Region.

By product type, product architecture is largely driven by the level of complexity of the transduction workflow. Standalone transduction enhancers offer the broadest scope of customization, with their chemistry modifiable per vector and cell type of choice, which LentiBOOST, TransDux, and LentiBlast represent through diverse mechanisms of action in enhancing viral-cell interaction. Transduction kits, meanwhile, represent a more integrated approach to viral transduction, either in terms of bundled components or standardized reagent formulation, thereby promoting reduced variability across an internal laboratory's process. The "Others" category subsumes additional specialized formats or reagent types that target specific vectors or cells. Consequently, the competitive landscape is increasingly characterized by a shift away from reagent abundance towards specialized formats that promote streamlining of the optimization process, in which translational end users would be especially invested.

By application, application-specific requirements are seen to drive demand. Cell therapy stands to benefit most from ex-vivo genetic modification of primary immune or stem cells, where high viability and functional readouts are paramount alongside high transduction efficiency, which a 2025 study on human and rhesus NK cell expansion and transduction highlights Poloxamer 407's potential in achieving 60% transduction rates on expanded rhesus NK cells with no reported decrement in viability or function. Gene therapies similarly involve introducing the therapeutic gene of interest into target cells, whereas vaccine development can potentially leverage viral vectors for encoded antigen production and immunogenicity. As such, cell and gene therapy applications are seen to have the most to gain from standardized, highly reproducible processes.

Transduction Enhancer Reagents Market- Geographical Insights

North America is primarily driven by the robustness of its commercial cell and gene therapy infrastructure and the adoption of transduction technologies by various therapeutic development pipelines. The U.S. regulatory environment continues to recognize the growing clinical relevance of genetically engineered cellular therapeutics in 2025, as evidenced by the delisting of REMS requirements for currently approved BCMA- and CD19-directed autologous CAR-T immunotherapies by the FDA in June. The FDA also approved an AAV-based gene therapy for spinal muscular atrophy in November 2025, which constitutes another regulatory milestone for the vector space. These trends have significant ramifications for enhancer suppliers, as the maturity of therapeutic platforms will increase the need for reproducible upstream cell-engineering processes, further bolstering the regional market for research grade and translational transduction reagents.

Europe constitutes a distinct opportunity due to its highly regulated environment for the development of advanced therapies, as well as the region's deep research expertise in the fields of gene and cell engineering. The EMA adopted its revised guideline pertaining to quality, non-clinical, and clinical requirements for investigational ATMPs with legal effect from July 2025. This highlights the need for controlled development and characterization of advanced therapies across the region. The European clinical development landscape was equally active in 2025, with an analysis published that year uncovering a total of 2,008 ATMP clinical trials listed across four databases, representing therapeutic approaches pertaining to gene, cell, and tissue-based therapeutics. Finally, European research institutions continue to probe the fundamental aspects of enhancer biology, such as recent findings from Inserm pertaining to Vectofusin and cyclosporin H's ability to overcome cellular restriction mechanisms. Collectively, this underscores the unique appeal of the European market for cell and gene editing technologies.

Transduction Enhancer Reagents Market- Competitive Landscape:

Competition is focused on diverse technical propositions, rather than a common standardized enhancer chemistry. Revvity is positioning its LentiBOOST technology as a non-cytotoxic solution spanning research and clinical applications, including challenging-to-transduce primary T cells, HSPCs, and NK cells. System Biosciences is targeting broad laboratory compatibility with its TransDux portfolio of reagents, whereas OZ Biosciences is differentiating its LentiBlast technology based on interactions at the membrane level, plus specialized products for stem cells and primary T cells. The competitive landscape is also moving beyond traditional reagents, with 2025 research identifying Poloxamer 407 as a new enhancer for NK cell transduction, whereas other studies are investigating combinations of transduction adjuvants and cellular restriction factor modulation. Competitive advantage is thus being driven by a focus on validated performance across cell types of clinical relevance and compatibility with standardized manufacturing.

Recent Developments:

In February 2025, Revvity announced that Abata Therapeutics had licensed LentiBOOST for engineered regulatory T-cell therapy development. The technology was selected to improve lentiviral transduction efficiency and vector copy number performance in Abata's engineered Treg program.

In June 2025, the University of New South Wales and collaborating researchers reported Poloxamer 407 as a transduction enhancer for lentiviral engineering of rhesus macaque and human NK cells. The study achieved transduction levels of up to 60% in expanded rhesus NK cells while maintaining reported cell viability and functionality.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Takara Bio Inc.
  • Bio-Techne
  • System Biosciences (SBI)
  • Miltenyi Biotec
  • Applied Biological Materials
  • OZ Biosciences
  • Revvity
  • Virongy
  • BPS Bioscience
  • komabiotech
  • ABP Biosciences
  • Merck KGaA (MilliporeSigma)
  • Lonza Group
  • Origene Technologies
  • Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Transduction Enhancers
  • Transduction Kits
  • Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Vaccines
  • Gene Therapy
  • Cell Therapy
  • Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY TARGET CELL TYPE- MARKET ANALYSIS, 2020 - 2033

  • Stem Cells
  • Immune Cells
  • Cancer Cells
  • Others

GLOBAL TRANSDUCTION ENHANCER REAGENTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Transduction Enhancer Reagents Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Transduction Enhancer Reagents Market Snippet by Product Type
    • 2.1.2. Transduction Enhancer Reagents Market Snippet by Application
    • 2.1.3. Transduction Enhancer Reagents Market Snippet by Target Cell Type
    • 2.1.4. Transduction Enhancer Reagents Market Snippet by Country
    • 2.1.5. Transduction Enhancer Reagents Market Snippet by Region
  • 2.2. Competitive Insights

3. Transduction Enhancer Reagents Key Market Trends

  • 3.1. Transduction Enhancer Reagents Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Transduction Enhancer Reagents Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Transduction Enhancer Reagents Market Opportunities
  • 3.4. Transduction Enhancer Reagents Market Future Trends

4. Transduction Enhancer Reagents Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Transduction Enhancer Reagents Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Transduction Enhancer Reagents Market Landscape

  • 6.1. Transduction Enhancer Reagents Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Transduction Enhancer Reagents Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Transduction Enhancers
    • 7.1.3. Transduction Kits
    • 7.1.4. Others

8. Transduction Enhancer Reagents Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Vaccines
    • 8.1.3. Gene Therapy
    • 8.1.4. Cell Therapy
    • 8.1.5. Others

9. Transduction Enhancer Reagents Market - By Target Cell Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Target Cell Type, 2025 & 2033 (%)
    • 9.1.2. Stem Cells
    • 9.1.3. Immune Cells
    • 9.1.4. Cancer Cells
    • 9.1.5. Others

10. Transduction Enhancer Reagents Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Transduction Enhancer Reagents Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Transduction Enhancer Reagents Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Transduction Enhancer Reagents Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Transduction Enhancer Reagents Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Transduction Enhancer Reagents Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By Target Cell Type, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Transduction Enhancer Reagents Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Takara Bio Inc.
    • 11.2.3. Bio-Techne
    • 11.2.4. System Biosciences (SBI)
    • 11.2.5. Miltenyi Biotec
    • 11.2.6. Applied Biological Materials
    • 11.2.7. OZ Biosciences
    • 11.2.8. Revvity
    • 11.2.9. Virongy
    • 11.2.10. BPS Bioscience
    • 11.2.11. komabiotech
    • 11.2.12. ABP Biosciences
    • 11.2.13. Merck KGaA (MilliporeSigma)
    • 11.2.14. Lonza Group
    • 11.2.15. Origene Technologies
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us